Pravastatin Sodium Tablet
Product Images NDC 84386-032

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 84386-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Pravastatin Fig1)

Figure 1 (Pravastatin Fig1)
This description is about a study showing the survival distributions for individuals with coronary heart disease death or nonfatal myocardial infarction over a period of five years since randomization. The data indicates a significant difference between the placebo and pravastatin groups, with a logrank P-value of 0.0001 suggesting a notable divergence in outcomes between the two groups.*
FDA Label Image

Package Label-principal Display Panel (10 mg (90 Tablets Bottle))

Package Label-principal Display Panel (10 mg (90 Tablets Bottle))
This is a description for a medication called Pravastatin Sodium Tablets, USP, containing 10 mg of pravastatin sodium in each tablet. Manufactured in Czech Republic by Teva Czech Industries, s.r.0., the tablets are distributed by Aurobindo Pharma USA, Inc. The usual dosage information can be found in the package insert, and it is advised to store the tablets at 20°C to 25°C in a controlled room temperature environment, away from moisture and light. The product is to be dispensed in a tight, light-resistant container with a child-resistant closure. It is important to keep this medication and all others out of the reach of children. The packaging includes 90 tablets and displays information such as NDC number and revision date. Additionally, the secondary packaging includes details like GTIN, serial number, expiry date, and LOT in the coding area for human-readable and 2D barcodes during packing.*
FDA Label Image

Package Label-principal Display Panel (20 mg (90 Tablets Bottle))

Package Label-principal Display Panel (20 mg (90 Tablets Bottle))
This is a description of a medication containing 20 mg of pravastatin sodium, USP, manufactured in the Czech Republic by Teva Czech Industries, s.r.o., and distributed by Aurobindo Pharma USA, Inc. It provides storage instructions, dosage information, and details on how the product should be dispensed. The text also includes a National Drug Code (NDC) number for identification purposes.*
FDA Label Image

Package Label-principal Display Panel (40 mg (90 Tablets Bottle))

Package Label-principal Display Panel (40 mg (90 Tablets Bottle))
This text provides information about a medication containing 40 mg of pravastatin sodium, a cholesterol-lowering drug, manufactured by TevaCzech Industries in the Czech Republic. The text also includes details on storage conditions, distribution by Aurobindo Pharma USA, and precautions such as protecting from moisture and light, as well as keeping the medication out of reach of children. Additionally, it mentions a child-resistant closure and provides a National Drug Code (NDC) number.*
FDA Label Image

Chemical Structure (Pravastatin Str)

Chemical Structure (Pravastatin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.